Abstract

BackgroundAcute respiratory failure (ARF) is a life-threatening complication in onco-hematology patients. Optimal ventilation strategy in immunocompromised patients has been highly controversial over the last decade. Data are lacking on patients presenting with ARF associating isolated cardiac dysfunction or in combination with another etiology. The aim of this study was to assess prognostic impact of initial ventilation strategy in onco-hematology patients presenting ARF with associated cardiac dysfunction.MethodsWe conducted an observational retrospective study in Institut Paoli-Calmettes, a cancer-referral center, assessing all critically ill cancer patients admitted to the ICU for a ARF with cardiac dysfunction.ResultsBetween 2010–2017, 127 patients were admitted. ICU and hospital mortality were 29% and 57%. Initial ventilation strategy was invasive mechanical ventilation (MV) in 21%. Others ventilation strategies were noninvasive ventilation (NIV) in 50%, associated with oxygen in 21% and high flow nasal oxygen (HFNO) in 29%, HFNO alone in 6% and standard oxygen in 23%. During ICU stay, 48% of patients required intubation. Multivariate analysis identified 3 independent factors associated with ICU mortality: SAPSII at admission (OR = 1.07/point, 95%CI = 1.03–1.11, p<0.001), invasive fungal infection (OR = 7.65, 95%CI = 1.7–34.6, p = 0.008) and initial ventilation strategy (p = 0.015). Compared to NIV, HFNO alone and standard oxygen alone were associated with an increased ICU mortality, with respective OR of 19.56 (p = 0.01) and 10.72 (p = 0.01). We realized a propensity score analysis including 40 matched patients, 20 in the NIV arm and 20 receiving others ventilation strategies, excluding initial MV patients. ICU mortality was lower in patients treated with NIV (10%), versus 50% in the other arm (p = 0.037).ConclusionIn onco-hematology patients admitted for ARF with associated cardiac dysfunction, severity at ICU admission, invasive fungal infections and initial ventilation strategy were independently associated with ICU mortality. NIV was a protective factor on ICU mortality.

Highlights

  • Acute respiratory failure (ARF) is the most frequent and severe life-threatening complication in onco-hematology patients, and remains the first reason for intensive care unit (ICU) admission in cancer patients [1]

  • Multivariate analysis identified 3 independent factors associated with ICU mortality: SAPSII at admission (OR = 1.07/point, 95%CI = 1.03–1.11, p

  • Compared to noninvasive ventilation (NIV), high flow nasal oxygen (HFNO) alone and standard oxygen alone were associated with an increased ICU mortality, with respective odds ratio (OR) of 19.56 and 10.72

Read more

Summary

Introduction

Acute respiratory failure (ARF) is the most frequent and severe life-threatening complication in onco-hematology patients, and remains the first reason for intensive care unit (ICU) admission in cancer patients [1]. In cancer patients admitted to the ICU for ARF, the need for intubation and invasive mechanical ventilation (MV) is associated with high mortality rates, reaching 70% [4, 5]. The main prognostic factors are MV requirement [1, 6, 7], ARF etiology [1,8], poor performance status, delayed ICU admission [9], associated organ dysfunctions [1] and allogeneic hematopoietic stem cell transplantation patients [10]. Acute respiratory failure (ARF) is a life-threatening complication in onco-hematology patients. The aim of this study was to assess prognostic impact of initial ventilation strategy in onco-hematology patients presenting ARF with associated cardiac dysfunction

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call